| 000 | 01902 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517151323.0 | ||
| 264 | 0 | _c20171108 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a1433-7339 | ||
| 024 | 7 |
_a10.1007/s00520-017-3697-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBody, Jean-Jacques | |
| 245 | 0 | 0 |
_aAn observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries. _h[electronic resource] |
| 260 |
_bSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _c09 2017 |
||
| 300 |
_a2823-2832 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDenosumab _xadministration & dosage |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aTime and Motion Studies |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aGatta, Francesca | |
| 700 | 1 | _aDe Cock, Erwin | |
| 700 | 1 | _aTao, Sunning | |
| 700 | 1 | _aKritikou, Persefoni | |
| 700 | 1 | _aWimberger, Pauline | |
| 700 | 1 | _aMebis, Jeroen | |
| 700 | 1 | _aPeeters, Marc | |
| 700 | 1 | _aPedrazzoli, Paolo | |
| 700 | 1 | _aCaraceni, Augusto | |
| 700 | 1 | _aAdamo, Vincenzo | |
| 700 | 1 | _aHechmati, Guy | |
| 773 | 0 |
_tSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer _gvol. 25 _gno. 9 _gp. 2823-2832 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00520-017-3697-5 _zAvailable from publisher's website |
| 999 |
_c27099961 _d27099961 |
||